Keogh, Ruth H.
Tanner, Kamaryn
Simmonds, Nicholas J.
Bilton, Diana
Funding for this research was provided by:
UK Research and Innovation (MR/S017968/1)
Medical Research Council (MR/M014827/1)
Article History
Received: 29 February 2020
Accepted: 1 June 2020
First Online: 30 June 2020
Competing interests
: NJS has received consultancy fees from Vertex, Roche, Chiesi and Pulmocide. He has received honoraria for speaking engagements from Vertex, Chiesi, Gilead, Teva and Zambon. The remaining co-authors have no conflicts of interest with the content of this article.